Executive Compensation Disclosure: Form 51-102F6 Explained
Executive compensation disclosure under Form 51-102F6 tells investors what Canadian issuers pay their named executive officers and directors and why. This guide explains who the NEOs are, what the CD&A and summary compensation table must contain, incentive and pension tables, termination and change-of-control benefits, Form 51-102F6V for venture issuers and proxy adviser expectations.

Key takeaways
- NEOs are the CEO, the CFO and the three other most highly paid executives earning over CAD 150,000.
- The summary compensation table covers three financial years with equity at grant-date fair value.
- The CD&A must explain objectives, elements, decisions, risk and hedging policies.
- Termination and change-of-control estimates use the last business day of the year.
- Venture issuers may use the simpler Form 51-102F6V.
What executive compensation disclosure covers in Canada
Executive compensation disclosure for Canadian reporting issuers is governed by Form 51-102F6 Statement of Executive Compensation, prescribed under National Instrument 51-102. The form requires a compensation discussion and analysis (CD&A), a summary compensation table, incentive plan award tables, pension disclosure, termination and change-of-control benefits, and director compensation. Venture issuers may instead use the simpler Form 51-102F6V. The statement usually appears in the management information circular for the annual meeting, and it is among the most read and most scrutinized parts of an issuer's disclosure.

The stated objective of the form is to communicate the compensation the company paid, made payable, awarded, granted or otherwise provided to each named executive officer and director, and the decision-making process behind it, and to explain how compensation relates to the overall stewardship and governance of the company. This note walks through each part of the statement, the judgment calls that cause most difficulty, and how proxy advisers and investors use the disclosure.
Who are the named executive officers?
The statement focuses on named executive officers (NEOs). Under the form, NEOs are:
- the chief executive officer (CEO);
- the chief financial officer (CFO);
- each of the three most highly compensated executive officers of the company, including its subsidiaries, other than the CEO and CFO, at the end of the most recently completed financial year whose total compensation was individually more than CAD 150,000; and
- each individual who would have been an NEO under item 3 but for the fact that they were no longer an executive officer at year-end.
Anyone who acted as CEO or CFO during any part of the year is an NEO. The CAD 150,000 threshold applies only to determining who is an NEO in the most recently completed financial year; once an individual is an NEO, the summary compensation table covers all three years for that person.
The compensation discussion and analysis
The CD&A explains the objectives of the compensation programme, what it is designed to reward, each element of compensation and why it is paid, how amounts are determined, and how each element fits with the overall objectives. It should cover:
- the role of the board and compensation committee, and any compensation consultants, including fees paid to them;
- benchmarking, including the peer group used and how it was selected;
- performance goals and how actual performance compared with them, including any discretion exercised;
- risk considerations, including whether the board has considered the risks of the compensation policies and practices;
- whether NEOs and directors are permitted to buy financial instruments designed to hedge or offset a decrease in the market value of equity granted as compensation; and
- a performance graph comparing cumulative total shareholder return over the five most recently completed financial years with a broad market index, and a discussion of how compensation trends compare.
The most common criticism of Canadian CD&As is that they describe processes without explaining outcomes. Investors want to understand why the CEO received what she received this year, and how much was at risk. A short summary at the start of the CD&A, showing target and actual pay for the CEO and the main performance outcomes, is now common practice among larger issuers and helps readers find the answers quickly.
The summary compensation table
The summary compensation table reports, for each NEO and for each of the three most recently completed financial years, salary, share-based awards, option-based awards, non-equity incentive plan compensation (annual and long-term), pension value, all other compensation and total compensation. Equity awards are valued at grant-date fair value, with the valuation methodology and key assumptions explained, and differences from accounting fair value described. Issuers may not add columns to the table, although they may add supplementary tables if they do not detract from the prescribed information.
| Item of Form 51-102F6 | Content | Common issues |
|---|---|---|
| Item 2: CD&A | Objectives, elements, decisions, risk, hedging, performance graph | Boilerplate; missing explanation of discretion |
| Item 3: Summary compensation table | Three years of compensation by element for each NEO | Grant-date fair value methodology; perquisites thresholds |
| Item 4: Incentive plan awards | Outstanding share- and option-based awards; value vested or earned during the year | Reconciling unvested and in-the-money values |
| Item 5: Pension plan benefits | Defined benefit and defined contribution plan tables | Compensatory versus non-compensatory changes |
| Item 6: Termination and change of control | Triggers, payments and estimated amounts | Double-trigger terms; estimates at year-end |
| Item 7: Director compensation | Director compensation table and narrative | Deferred share units; equity ownership requirements |
Incentive plan awards and pension benefits
Item 4 requires a table of outstanding share-based and option-based awards at year-end for each NEO, including the number and value of unexercised in-the-money options and unvested share units, and a table of the value vested or earned during the year. These tables let investors see the overhang of past awards and the realized value, which may differ greatly from grant-date values. Item 5 requires tables for defined benefit and defined contribution pension plans, distinguishing compensatory changes (such as service cost and plan amendments) from non-compensatory changes (such as interest and investment returns).
Termination and change-of-control benefits
Item 6 requires a description of each contract, agreement, plan or arrangement that provides for payments on resignation, retirement, termination, a change of control or a change in responsibilities, including the triggering events, the payments and benefits, how they are determined, any conditions such as non-competes, and an estimate of the incremental payments assuming the triggering event occurred on the last business day of the year. Investors pay close attention to "single-trigger" change-of-control payments, which are paid on a change of control without a subsequent termination, and to equity acceleration terms. Our note on executive employment agreements discusses how these provisions are drafted.
Calculate termination and change-of-control estimates using the actual agreement terms and the year-end share price, and reconcile them with the employment agreements on file. Discrepancies between the circular and the contracts are a frequent source of disputes when an executive is later terminated.
Director compensation
Item 7 requires a director compensation table showing fees, share-based and option-based awards, non-equity incentive plan compensation, pension value and all other compensation for each director who is not an NEO, together with narrative on the director compensation programme, outstanding awards and value vested during the year. Many Canadian issuers pay directors partly in deferred share units, which must be held until the director leaves the board, and set share ownership guidelines for directors. Those features should be explained clearly, including how deferred units are valued and when they are paid out.
Venture issuers and Form 51-102F6V
Venture issuers may use Form 51-102F6V, which requires a simpler table of compensation excluding compensation securities, a table of compensation securities granted or issued, a description of stock option plans and other incentive plans, employment and consulting agreements, oversight and description of director and NEO compensation, and pension disclosure. It omits the performance graph and some of the detailed incentive plan tables. Even for venture issuers, investors expect a clear explanation of how compensation decisions were made, and exchange rules require shareholder approval of security-based compensation plans.
Clawbacks, say on pay and proxy adviser scrutiny
Executive compensation disclosure is also shaped by practices beyond the form. Many Canadian issuers have adopted clawback policies that allow recovery of incentive compensation after a restatement or misconduct, and issuers listed in the United States must comply with US exchange clawback listing standards. Many large Canadian issuers hold advisory "say on pay" votes voluntarily; see our note on majority voting and say on pay under the CBCA. Proxy advisers assess pay-for-performance alignment, the proportion of compensation at risk, the use of discretion, and severance terms, and their recommendations can influence vote outcomes significantly.
Non-GAAP measures used to determine incentive payouts, such as adjusted EBITDA, must be explained in the CD&A and, where the measure is also a non-GAAP financial measure in public disclosure, presented consistently with NI 52-112; see our note on non-GAAP financial measures.
Executive compensation disclosure and the CBCA amendments not yet in force
Executive compensation disclosure may expand for federally incorporated companies. Amendments to the Canada Business Corporations Act enacted in 2019 (S.C. 2019, c. 29) would require a "prescribed corporation" to develop an approach to the remuneration of its directors and senior management (s. 125.1), to place that approach before shareholders at every annual meeting for a non-binding vote and disclose the results (s. 172.4), and to disclose prescribed information on the recovery of incentive benefits, that is, clawbacks (s. 172.3).
The CBCA consolidation current to 19 October 2026 lists these provisions as amendments not in force; they also depend on regulations defining which corporations are covered. Issuers incorporated under the CBCA should monitor whether they are brought into force, because they would make say on pay and clawback disclosure mandatory for prescribed corporations.
Common deficiencies in executive compensation disclosure
Regulators' continuous disclosure reviews and investor feedback point to recurring weaknesses in executive compensation disclosure:
- CD&As that list compensation elements without explaining how the committee set the amounts actually paid;
- performance goals described only qualitatively, with no explanation of why payouts were above or below target;
- undisclosed or poorly explained use of discretion to adjust formula outcomes;
- inconsistencies between the summary compensation table and the incentive plan tables;
- termination estimates that do not match the agreements filed or described elsewhere;
- peer groups that change from year to year without explanation.
Each of these can attract regulatory comment and, more commonly, negative proxy adviser recommendations. A clear narrative that links pay outcomes to performance and strategy is the best defence, supported by tables that reconcile with each other and with the financial statements.
Preparing the statement: a practical timeline
- Before year-end. Confirm NEOs, peer group and any changes to plans; collect grant data and valuation assumptions.
- At year-end. Finalize incentive outcomes against goals; calculate termination estimates using the year-end share price.
- First draft. Prepare the CD&A, tables and director compensation section, coordinating with the compensation consultant and payroll.
- Committee review. The compensation committee reviews the draft, focusing on whether the narrative explains decisions and outcomes.
- Legal and audit review. Check consistency with financial statements, plan documents, employment agreements and insider reports.
- Board approval and filing. Include in the circular and file within the required timelines.
How TRW & Co helps with executive compensation disclosure
We draft and review executive compensation disclosure under Forms 51-102F6 and 51-102F6V, advise compensation committees on plan design and governance, prepare termination and change-of-control analyses, and help issuers respond to proxy adviser and investor concerns. See our corporate governance page and our continuous disclosure compliance page. This note is general information, not legal advice. To discuss your circular, contact us.
Frequently asked questions
Who is a named executive officer under Form 51-102F6?
The CEO, the CFO, each of the three most highly compensated other executive officers (including at subsidiaries) whose total compensation exceeded CAD 150,000 in the most recently completed financial year, and anyone who would have been in that group but was no longer an executive officer at year-end.
How many years does the summary compensation table cover?
Three: the three most recently completed financial years, for each NEO, showing salary, share-based and option-based awards, non-equity incentive plan compensation, pension value, all other compensation and total compensation.
How are equity awards valued in the table?
At grant-date fair value, with the valuation methodology and key assumptions described. If grant-date fair value differs from the accounting fair value in the financial statements, the difference and the reasons must be explained.
Can venture issuers use a shorter form?
Yes. Venture issuers may use Form 51-102F6V, which requires a compensation table excluding compensation securities, a table of compensation securities, descriptions of incentive plans and agreements, and narrative on how compensation is overseen, without some of the detailed tables in Form 51-102F6.
Do Canadian issuers have to hold say-on-pay votes?
Many large issuers hold advisory votes voluntarily. CBCA amendments enacted in 2019 would require prescribed corporations to hold a non-binding vote on their approach to remuneration, but they were not in force as of the 19 October 2026 consolidation. US-listed issuers must also comply with US exchange clawback standards.
Sources
- Canada Business Corporations Act (amendments not in force: ss. 125.1, 172.3, 172.4)
- Form 51-102F6 Statement of Executive Compensation (OSC unofficial consolidation)
- Form 51-102F6V Statement of Executive Compensation – Venture Issuers (OSC unofficial consolidation)
- NI 51-102 Continuous Disclosure Obligations (BCSC consolidation, 22 Sept 2026)
General information only, not legal advice. References to statutes, courts and authorities describe published law and practice at the date shown.


